GHRH analog vs GHRP: two ways to raise growth hormone, hitting two different receptors. Why the answer is almost always 'both'.
Sermorelin and Ipamorelin are the classic GHRH + GHRP pairing. Sermorelin engages the GHRH receptor (upstream signal), Ipamorelin engages the ghrelin/GHS-R1a receptor (downstream amplifier). Together they produce a stronger, cleaner GH pulse than either alone.
| Sermorelin | Ipamorelin | |
|---|---|---|
| Class | GHRH (1-29) analog | GHRP / ghrelin receptor agonist |
| Receptor | GHRH-R | GHS-R1a (ghrelin) |
| Sequence length | 29 amino acids | 5 amino acids |
| Half-life | 10–20 minutes | ~2 hours |
| Cortisol / prolactin effect | Minimal | Minimal (selectivity is its hallmark) |
| Best used | Paired with a GHRP | Paired with a GHRH analog |
Sermorelin is a 29-amino-acid GHRH analog representing the bioactive fragment of natural growth hormone–releasing hormone. It has one of the longest track records in clinical-research literature among GH-supporting peptides.
Activates pituitary GHRH receptors to stimulate natural GH secretion.
Ipamorelin is a pentapeptide growth hormone secretagogue. It is valued in research for its selectivity — stimulating GH release with minimal effect on cortisol or prolactin in published studies.
Selective ghrelin/GHS-R1a receptor agonist that triggers GH release from the anterior pituitary.
This is a canonical complementary pair, not a competition. Most published GH-support protocols use both together.
The table above compares published characteristics, not outcomes for any individual. Mechanism, half-life, and dosing cadence are properties of the molecule; response, tolerability, and suitability are properties of the person. Trial averages describe populations and say nothing definitive about a single case.
All peptide products referenced are intended solely for research, investigational, or licensed professional use. They are not FDA-approved and are not intended to diagnose, treat, cure, or prevent any disease. Consult a licensed medical practitioner before any personal or clinical use.
Both target the GHRH receptor. CJC-1295 is engineered for greater stability and longer action than the parent Sermorelin molecule.
No. Ipamorelin is a peptide secretagogue that supports endogenous GH release; it is not an anabolic steroid.
Published research shows Ipamorelin is unusually clean on cortisol and prolactin compared to older GHRPs — a major reason it's preferred in modern protocols.